oalib

OALib Journal期刊

ISSN: 2333-9721

费用：99美元

投稿

时间不限

( 2026 )

( 2025 )

( 2024 )

( 2023 )

自定义范围…

匹配条件： “Endoscopic submucosal tunneling technique” ，找到相关结果约1000条。
列表显示的所有文章，均可免费获取
第1页/共1000条
每页显示 条
Endoscopic trans-esophageal submucosal tunneling surgery: A new therapeutic approach for diseases located around the aorta ventralis
En-Qiang Ling Hu,Ning-Li Chai,Qian-Qian Chen,Shun-Chang Jiao,Ying Xiong
- , 2019, DOI: 10.3748/wjg.v25.i1.85
Abstract:
Endoscopic submucosal dissection and submucosal tunneling endoscopic resection for obstructive lipomas of the foregut and hindgut
- , 2019, DOI: 10.1016/j.vgie.2019.03.002
Abstract:
术前标识对黏膜下隧道内发现食管黏膜下肿瘤的作用研究
汪志兵,姜宗丹,张振玉,张予蜀
- , 2017, DOI: 10.3969/j.issn.1007-1989.2017.06.011
Abstract: 摘要： 目的??探讨术前标识对行隧道内镜方法发现食管黏膜下肿瘤的作用。方法?将2012年3月-2016年8月于该科室明确诊断病变大小为1.0～2.0 cm的食管黏膜下肿瘤40例随机分为A、B两组，A组采用在距病变3.0 cm处常规行经黏膜下隧道内镜切除术（STER），B组采取先从食管腔内病变处行黏膜下盐水注射，再由下而上成一条直线多点黏膜下注射至距病变3.0 cm处再行STER法，记录两组患者发现瘤体时间。结果?A组平均用时（420.0±25.0）s，B组平均用时（300.0±25.0）s，B组用时更少，两组间差异有统计学意义。结论?采取标识法行STER法较传统STER法更具优势。
Abstract: Objective?To investigate the preoperative identification of esophageal submucosal tumor by endoscope.?Methods?40 patients of esophageal submucosal tumors with lesions range from 1.0 to 2.0 cm from March 2012 to August 2016 were randomly divided into A, B groups. Patients in group A underwent submucosal tunneling endoscopic resection (STER) 3.0 cm from the lesions, while patients in group B first underwent submucosal injection of saline to mark the lesions, then perform STER in the same way. Then record the time of checking. ?Results?The average time of group A was (420.0 ± 25.0) s, the average time of B group was (300.0 ± 25.0) s, there was statistical differences between the two groups.?Conclusion?Preoperative identification of the lesions before STER holds more advantages.
Subpyloric tunneling endoscopic submucosal dissection: a novel technique for safe and successful removal of a challenging duodenal submucosal lesion
- , 2019, DOI: 10.1016/j.vgie.2019.03.019
Abstract:
内镜隧道剥离术在结直肠病变中的临床应用
周巍,于红刚
- , 2018,
Abstract: 摘要： 摘要：目的??观察内镜隧道剥离术在结直肠病变中的应用价值。方法?回顾性分析2017年4月-2017年6月武汉大学人民医院收治的17例结直肠病变患者临床资料，17例患者中8例患者经内镜隧道剥离术治疗（隧道组），9例行内镜黏膜下剥离术（ESD）治疗（ESD组）。初步评估内镜隧道剥离术治疗结直肠病变的有效性及安全性。结果?两组在性别比例、病灶部位、病灶大小以及术后病理结果上差异均无统计学意义（P?>0.05）。所有病变均一次性完整切除；隧道组平均手术时间（45.0±15.0）min，ESD组平均手术时间（67.0±17.0）min；隧道组术中出血发生率12.5%（1/8），ESD组66.7%（6/9），组间差异明显（P?<0.05）。隧道组术中穿孔发生率0.0%，ESD组22.2%（2/9）；ESD组有1例出现术后迟发性出血；两组均未出现术后迟发性穿孔；隧道组术后感染发生率12.5%（1/8），ESD组11.1%（1/9），以上组间差异均无统计学意义（P?>0.05）。随访中无病例失访，术后1个月结肠镜复查两组均未发现病灶残留或复发。结论?内镜隧道剥离术和ESD均可以用于结直肠病变的治疗，相比传统ESD技术，内镜隧道剥离术在手术时间、术中出血率上更有优势，有望成为治疗结直肠病变的主要方法。
Abstract: Abstract: Objective?To investigate the application value of submucosal tunneling endoscopic resection in the treatment of colorectal lesions.?Methods?The clinical data of 17 patients who were found to have colorectal mucosal lesions by colonoscopy and underwent endoscopic submucosal dissection (ESD) and submucosal tunneling endoscopic resection treatment from April 2017 to June 2017 were retrospectively analyzed. There were 8 cases in study group with submucosal tunneling endoscopic resection treatment, 9 cases were treated with ESD in control group.?Results?There were no statistical differences between the two groups in gender, lesion location, lesion size and postoperative pathological diagnosis (P?>?0.05). All lesions in the two groups were all curative and enbloc resection. The mean operating time was significantly shorter in study group (45.0?±?15.0)?min than that in control group (67.0?±?17.0)?min; The rates of bleeding during operating were 12.5% and 66.7 % respectively. There were statistical difference between the two groups in the above data (P? ?0.05). No residual lesion or recurrent lesion was found in the follow-up one month after operating.?Conclusion?Submucosal tunneling endoscopic resection and ESD can be used in the treatment of colorectal lesions. Compared with ESD, submucosal tunneling endoscopic resection has more advantages in the operating time and blood loss. Submucosal tunneling endoscopic resection is a safe and effective treatment for patients with colorectal lesions. It is expected to become the main method of treatment of colorectal lesions.
Endoscopic full thickness resection versus submucosal tunneling endoscopic resection for removal of submucosal tumors: a review article
Michel Kahaleh,Peter Dellatore,Vicky Bhagat
- , 2019, DOI: 10.21037/tgh.2019.05.03
Abstract:
Clinical analysis of submucosal tunneling endoscopic resection in treating esophageal submucosal tumors
Fu Xinjuan,Li Bin,Liu Hualin,Liu Hui,Shi Xiuju,Xu Hongwei
- , 2017,
Abstract: Background: Inspired by peroral Endoscopic Myotome (POEM), a new technique named Submucosal Tunneling Endoscopic Resection (STER) was developed for the treatment of submucosal gastrointestinal tumors. Objective: To evaluate the clinical security and the feasibility of Submucosal Tunneling Endoscopic Resection (STER) for treating the submucosal tumors of esophageal. Methods: Collecting cases during 2011 November to 2014 December in Shandong Provincial Hospital, all patients were diagnosed as esophageal submucosal tumors by Ultrasonography Endoscopic (EUS), and Computed Tomography (CT) scan. 58 patients were treated with STER, and 30 patients were treated with ESE, to observe two group’s indicators such as operation time, intraoperative and postoperative complications, tumor size, pathology and postoperative hospitalization days. Results: All 58 patients’ tumors were resected en bloc successfully by STER at one time, the en bloc resection rate was 100%, the mean operation time was 63.24 ± 15.10 min, a bit shorter than the ESE group (71.97 ± 25.46 min), and there was significant difference between two groups (t=2.018, P=0.047). The mean size of the tumors was 2.07 ± 0.8 cm, larger than ESE group (1.28 ± 0.63 cm), and there was significant difference between two groups (t=4.659, P=0.013). No intraoperative perforation occurred in STER, and fevers 9 cases (15.8%), subcutaneous emphysema 3 cases (5.3%) and pneumothorax 2 cases (3.5%) were observed post operation, all patients recovered after conservative treatment. No delayed bleeding and secondary infection and esophageal fistula. The mean postoperative hospitalization days were 5.72 ± 2.24 d, no significant difference was observed compared with ESE group (6.27 ± 3.10 d). The incidence rate of fever, subcutaneous emphysema and pneumothorax of STER group were lower than the ESE group, but no statistical significance was observed. Three months later, gastroscope or Ultrasonography (EUS) review showed wound healing, and no residual tumor or relapse. Conclusion: STER is a safe and feasible method for treating esophageal sumucosal tumors, and it worth of clinical promotion
Submucosal tunneling endoscopic resection of upper gastrointestinal tract tumors arising from muscularis propria
Aakash Desai,Deepanshu Jain,Ejaz Mahmood,Shashideep Singhal
- , 2017, DOI: 10.20524/aog.2017.0128
Abstract: The management of incidentally discovered small upper gastrointestinal (GI) tract submucosal tumors (SMT) remains debatable. In this review, we summarize the evolving experience with submucosal tunneling endoscopic resection (STER) of upper GI SMTs originating from the muscularis propria. From 16 original studies, we reviewed a total of 703 patients with 736 lesions. Of these, 436 were located in the esophagus, 146 in the esophagogastric junction (EGJ) and 154 in the stomach. The composite complete resection rate (CRR) for STER of upper GI tumors arising from the muscularis propria layer was 99.8% (445/446). The composite CRR for STER of esophageal, EGJ and gastric SMTs arising from the muscularis propria layer was 100% (208/208),100% (78/78)and 100% (115/115), respectively. The composite en bloc resection rate (EBRR) for STER of upper GI tumors arising from the muscularis propria layer was 94.6% (679/718). The composite EBRR for STER of esophageal, EGJ and gastric SMTs arising from the muscularis propria layer was 98.6% (205/208), 96.2% (75/78) and 97.9% (95/97), respectively. Tumor recurrence rate was 0%. The reported complication rate for STER was high but the majority responded to conservative management. STER is a minimally invasive and efficacious alternative to surgery, especially for patients with small tumors (<3 cm). Careful selection of candidates remains crucial for excluding potentially malignant tumors
Endoscopic submucosal tunnel dissection for large superficial esophageal squamous cell neoplasms
En-Qiang Linghu,Hui-Kai Li,Ya-Qi Zhai
- , 2016, DOI: 10.3748/wjg.v22.i1.435
Abstract:
Consensus on the digestive endoscopic tunnel technique
Ai-Ming Yang,Bin Zhang,Bing Hu,De-Liang Liu,Dong Wan Seo,En-Qiang Linghu,Fang Yao,Gui-Qi Wang,Gui-Yong Peng,Hai-Feng Liu,Hong Xu,Hong-Gang Yu,Hui-Kai Li,James Lau,Jian-Qiu Sheng,Jian-Yu Hao,Jun Liu,Long Rong,Mei-Dong Xu,Mouen A Khashab,Ning-Li Chai,Pateek Sharma,Peng Li,Philip WY Chiu,Ping-Hong Zhou,Qi Wu,Rui Li,Shu-Tang Han,Shu-Tian Zhang,Shui-Sheng Shi,Shui-Xiang He,Si-Yu Sun,Tong Dang,Wei Gong,Wei-Gang Chen,Wei-Hong Sha,Wen Wang,Xiao-Feng Zhang,Xiao-Gang Liu,Xiao-Jun Huang,Ya-Qi Zhai,Ying-Cai Ma,Yong-Hui Huang,Yu Bao,Zhao-Shen Li,Zhen-Dong Jin,Zhi-Guo Liu
- , 2019, DOI: 10.3748/wjg.v25.i7.744
Abstract:
第1页/共1000条
每页显示 条


Home
Copyright © 2008-2020 Open Access Library. All rights reserved.